These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36860160)

  • 1. Incidence, mortality, and risk factors associated with carbapenem-resistant Acinetobacter baumannii bacteremia within 30 days after liver transplantation.
    Min EK; Yim SH; Choi MC; Lee JG; Joo DJ; Kim MS; Kim DG
    Clin Transplant; 2023 May; 37(5):e14956. PubMed ID: 36860160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem-resistant Acinetobacter baumannii Bacteremia in Liver Transplant Recipients.
    Kim YJ; Kim SI; Lee YD; Choi HJ; Choi JY; Yoon SK; You YK; Kim DG
    Transplant Proc; 2018 May; 50(4):1132-1135. PubMed ID: 29731080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
    Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care unit.
    Kim SY; Jung JY; Kang YA; Lim JE; Kim EY; Lee SK; Park SC; Chung KS; Park BH; Kim YS; Kim SK; Chang J; Park MS
    J Korean Med Sci; 2012 Aug; 27(8):939-47. PubMed ID: 22876063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem-resistant Acinetobacter baumannii acquired before liver transplantation: Impact on recipient outcomes.
    Freire MP; Pierrotti LC; Oshiro IC; Bonazzi PR; Oliveira LM; Machado AS; Van Der Heijden IM; Rossi F; Costa SF; D'Albuquerque LA; Abdala E
    Liver Transpl; 2016 May; 22(5):615-26. PubMed ID: 26684547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
    Huang ST; Chiang MC; Kuo SC; Lee YT; Chiang TH; Yang SP; Ti-Yin ; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2012 Oct; 45(5):356-62. PubMed ID: 22575430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case-control study.
    Henig O; Weber G; Hoshen MB; Paul M; German L; Neuberger A; Gluzman I; Berlin A; Shapira C; Balicer RD
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2063-8. PubMed ID: 26205665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii bacteremia in neonatal intensive care unit: a case-case-control study.
    Thatrimontrichai A; Apisarnthanarak A; Chanvitan P; Janjindamai W; Dissaneevate S; Maneenil G
    Pediatr Infect Dis J; 2013 Feb; 32(2):140-5. PubMed ID: 22935872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in
    Liu Y; Wang Q; Zhao C; Chen H; Li H; Wang H; Cares Network OBOT
    J Med Microbiol; 2020 Jul; 69(7):949-959. PubMed ID: 32584215
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis.
    Yang YS; Lee YT; Tsai WC; Kuo SC; Sun JR; Yang CH; Chen TL; Lin JC; Fung CP; Chang FY
    BMC Infect Dis; 2013 Jul; 13():311. PubMed ID: 23841753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.
    Anunnatsiri S; Tonsawan P
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):693-703. PubMed ID: 21706949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
    Liu CP; Shih SC; Wang NY; Wu AY; Sun FJ; Chow SF; Chen TL; Yan TR
    J Microbiol Immunol Infect; 2016 Dec; 49(6):934-940. PubMed ID: 25553994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients.
    Kim SB; Min YH; Cheong JW; Kim JS; Kim SJ; Ku NS; Jeong SJ; Han SH; Choi JY; Song YG; Kim JM
    Scand J Infect Dis; 2014 Feb; 46(2):81-8. PubMed ID: 24325335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis.
    Du X; Xu X; Yao J; Deng K; Chen S; Shen Z; Yang L; Feng G
    Am J Infect Control; 2019 Sep; 47(9):1140-1145. PubMed ID: 31003750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors and resistance patterns of invasive
    Ge YL; Shan QW; Qiu Y; Zhou SP; Cheng YB; Wang F; Yang JW; Wan CM; Zhu Y; Xu Y; Chen MX; Lin DJ; Zhu CH; Zeng M
    Zhonghua Er Ke Za Zhi; 2022 Aug; 60(8):762-768. PubMed ID: 35922185
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections.
    Esterly JS; Griffith M; Qi C; Malczynski M; Postelnick MJ; Scheetz MH
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4844-9. PubMed ID: 21825287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia.
    Nutman A; Glick R; Temkin E; Hoshen M; Edgar R; Braun T; Carmeli Y
    Clin Microbiol Infect; 2014 Dec; 20(12):O1028-34. PubMed ID: 24930471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the early mortality of adult patients with carbapenem-resistant Acinetobacter baumannii bacteremia during 11 years at an academic medical center.
    Choi SH; Cho EB; Chung JW; Lee MK
    J Infect Chemother; 2019 Jan; 25(1):6-11. PubMed ID: 30342838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.
    Zheng YL; Wan YF; Zhou LY; Ye ML; Liu S; Xu CQ; He YQ; Chen JH
    Am J Infect Control; 2013 Jul; 41(7):e59-63. PubMed ID: 23523521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of carbapenem-resistant Acinetobacter baumannii infections on acute pancreatitis patients.
    Wu D; Huang Y; Ding J; Jia Y; Liu H; Xiao J; Peng J
    Pancreatology; 2022 Mar; 22(2):194-199. PubMed ID: 34924296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.